SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-16-541467
Filing Date
2016-04-14
Accepted
2016-04-14 16:32:03
Documents
55
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q AMENDMENT NO. 1 d179913d10qa.htm 10-Q/A 322670
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER d179913dex311.htm EX-31.1 9428
3 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER d179913dex321.htm EX-32.1 3309
  Complete submission text file 0001193125-16-541467.txt   3074426

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT tpiv-20150630.xml EX-101.INS 589870
5 XBRL TAXONOMY EXTENSION SCHEMA tpiv-20150630.xsd EX-101.SCH 41134
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tpiv-20150630_cal.xml EX-101.CAL 43521
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tpiv-20150630_def.xml EX-101.DEF 148192
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE tpiv-20150630_lab.xml EX-101.LAB 277154
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tpiv-20150630_pre.xml EX-101.PRE 241658
Mailing Address 50 N LAURA STREET SUITE 2500 JACKSONVILLE FL 98102
Business Address 50 N LAURA STREET SUITE 2500 JACKSONVILLE FL 98102 (206) 504-7278
TAPIMMUNE INC (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: NV | Fiscal Year End: 0220
Type: 10-Q/A | Act: 34 | File No.: 000-27239 | Film No.: 161572084
SIC: 2834 Pharmaceutical Preparations